Spruce Biosciences, Inc.
SPRB
$60.10
$0.040.06%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/12/2026
-
MarketBeat
3/11/2026
-
Ticker Report
3/10/2026
-
Ticker Report
3/10/2026
-
MarketBeat
3/10/2026
-
MarketBeat
3/10/2026
-
Ticker Report
3/10/2026
-
MarketBeat
3/10/2026
-
TipRanks Financial Blog
3/9/2026
-
FiercePharma
3/9/2026
-
TipRanks Financial Blog
3/9/2026
-
The Fly
3/9/2026
-
Business Wire
3/9/2026
-
Ticker Report
3/9/2026
-
Business Wire
3/5/2026
-
MarketBeat
3/3/2026
-
Insider Monkey
3/3/2026
-
Insider Monkey
3/2/2026
-
Business Wire
3/2/2026
-
MarketBeat
3/1/2026
-
MarketBeat
2/23/2026
-
MarketBeat
2/19/2026
-
TipRanks Financial Blog
2/19/2026
-
The Fly
2/19/2026
-
The Fly
2/18/2026
-
Stocktwits News Feed
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, March 9, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of Apr 13 and 17 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
415 343 5986
Address
611 Gateway Boulevard
South San Francisco, CA 94080
South San Francisco, CA 94080
Country
Year Founded
Business Description
Sector
Spruce Biosciences, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders. The company develops TA-ERT, a fusion protein...
more